Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan

16
Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan

description

Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan. Current legislative system of the RK (summary) Prescription procedure and drug delivery Consumption statistics (International data). - PowerPoint PPT Presentation

Transcript of Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan

Page 1: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Procedure for narcotic drugs use for medical purposes in the Republic of Kazakhstan

Page 2: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Current legislative system of the RK (summary) Prescription procedure and drug delivery Consumption statistics (International data)

Page 3: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

General description of the current legislative system of the Republic of Kazakhstan

Republic of Kazakhstan Code dated

18 September

2009 No 193-IV “On

Nation Health and

Health System” (as amended

dated 19.03.2010)

Republic of Kazakhstan Act dated 10 July 1998 No 279-I«On narcotic, psychotropic

substances and precursors, and countermeasure

s to their trafficking and

abuse»;

Rebublic of Kazakhstan Act

dated 1 July 1998 No 257-I “On joining of

the Republic of Kazakhstan to

the Single Convention of Narcotic Drugs dated 1961 as amended, in accordance

with Protocol 1972 on

amendments to Single

Convention of Narcotic Drugs dated 1961”

RK Act dated 29 July 1998

No 246-I “On joining

of the Republic of Kazakhstan

to the United Nations

Convention against illicit

traffic in narcotic

drugs and psychotropic substances”

Presidential Decree of the

Republic of Kazakhstan

dated 13 September

2004 No 1438 “On

Government Health

Reforming and

Development Program of

the Republic of Kazakhstan

for 2005-2010”

Government Resolution of the RK dated 15 December 2009 No2136 “On approval

of the warranted

free medical care

capacity”

Government Resolution of

the Republic of Kazakhstan

dated 26 November

2009 No 1938 “On adoption of the list of population categories subject to

palliative care and nursing”

Government Resolution of the Republic

of Kazakhstan

dated 15 December 2009 No 2135 “On

adoption of regulations

on drug provision for population”

Government Resolution of the Republic

of Kazakhstan dated 30

March 2012 No 396 “On adoption of

regulations for medicinal use

narcotic, psychotropic substances

and precursors, subject to

control in the Republic of

Kazakhstan”

Page 4: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Prescription procedure and delivery of drugs, containing narcotic, psychotropic substances and precursors in the Republic of Kazakhstan

Resolution of the Government of the RK No 396 dated 30 March 2012 On adoption of regulations for medical use of the narcotic, psychotropic substances and

precursors which are subject to control in the Republic of Kazakhstan

Page 5: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Prescription blank

Drugs containing narcotic, psychotropic substances and precursors included in the List are prescribed on the special prescription pink format A6 blank printed typographically with the code, blank number and protection level. Code includes an administrative-territorial unit identification number of the Republic of Kazakhstan

Page 6: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Prescription blank

Narcotic substance conaining drug prescriptions of the List tabulation are valid for 7 days

Special prescription blank is to be signed by the Health organization Manager or Deputy and to be verified by the seal of health organization. Herein the seal is placed at the cut line. Moreover, the stamp of the health organization is set, the medical documentation number, prescribing physician’s full name,

and patient’s full name and home address are indicated.

Drugs containing narcotic, psychotropic substances are prescribed to out-patients on the special prescription pink format A6 blank printed

typographically with the code, blank number and protection level.

Code includes an administrative-terrotorial unit identification number of the Republic of Kazakhstan

Page 7: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Special prescription blank form

Prescription No._______ Prescription No._______

Code_________________ Code_________________

Prescription date “___”____________20____ Patient’s full name age_____Address _________________________District No. ______________,Patient’s medical documentation No. ___________________

Physicians full name Rp

Prescription date “___”____________20____ Patient’s full name age_____Address _________________________District No. ______________,Patient’s medical documentation No. ___________________

Physicians full name Rp

Physician’s signature and personal seal_________________ L.)

Physician’s signature and personal seal_________________O.

No corrections must be made Counterfoil is kept in the Health Organization Blank number

No corrections must be made Counterfoil is kept in the Health Organization Blank number

Page 8: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Signature

“individuals taking drugs containing narcotic, psychotropic substances for therapeutic purposes must have the document confirming the legality of these drugs purchase. Form of this document is to be established by authorized health body” as agreed by the Committee. This document is named a “signature”

Page 9: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Signature Name of the pharmaceutical organization

________________________________________________________________________ CODE ________________________________ Prescription No. ________________,

Prescription date____________________ Name of the pharmaceutical organization

________________________________________________________________________ Rp:

_________________________________________________________________________________________________

____________________________________________________________________________________________________

____________________________________________________________________________________________________

____________________________________________________________________________________________________

Mode of administration Physician’s full name________________________________________________________ Prepared by________________________________________________________ Checked by ________________________________________________________ Released by ________________________________________________________ Date _______________________________________________________________

Page 10: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Narcotic substance containing drug storage and inventory procedure

Individuals

• Special permission• Physician’s conclusion

regarding absence of narcotic drug abuse

• List of persons is to be approved by the Health organization Manager annually.

Facility

• Is in blocking state• Outside office hours

these are to be sealed up

• Keys and seal press are to be kept in a responsible person

Documentation • All documents on the narcotic substances containing drugs to be kept properly for five years.

Page 11: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Narcotic substance containing drug destruction procedure

• Destruction fact is registered by act in compliance with these Regulations.

• powders and tablets, plasters (transdermal therapeutic systems) by burning, ampules by crushing

• Drugs are destroyed by standing commission of the institution not later than 30th day monthly

• Subject to destruction: empty ampoules, used plasters

What?Who?

TotalHow?

Page 12: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Maximum allowance for narcotic substance containing drug prescription and release

Name Unit Quantity

Buprenorphine 0.2 mg sublingual tablet tablet 20

Buprenorphine 0.6 mg in 1 ml ampules 10

Buprenorphine 0.6 mg in 1 ml ampules 20

Codeine grams 0.2Codeine containing antitussive tablet (codthermops, codturpin)

tablet 20

Morphine grams 0.3

Omnopon grams 0.1Trimeperidine grams 0.25Prosidol grams 0.25Ethylmorphine (Dionne) grams 0.2Ephedrine hydrochloride, pseudoephedrine grams 0.6

Page 13: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan

Western Asia: Average opioid consumption 1997-1999, 2007-2009

Page 14: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan
Page 15: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan
Page 16: Procedure  for narcotic drugs use for medical purposes in  the  Republic of Kazakhstan